期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

雄激素受体在乳腺癌中的表达及临床意义 被引量：5

下载PDF
导出
摘要 目的研究雄激素受体(AR)在乳腺癌组织中的表达及临床意义。方法用免疫组化法检测AR在乳腺癌组织中的表达,并结合临床、病理资料进行分析。结果乳腺癌组织中的AR表达与肿瘤大小呈负相关(r=-0.403,P<0.05),与年龄、是否绝经、病理学类型、有无脉管瘤栓、淋巴结转移无相关性(P>0.05),与组织学分级呈负相关(r=-0.447,P<0.05),与ER、PR、Her-2、Ki-67的无相关性(P>0.05)。结论 AR与乳腺癌有相关性,可以作为一个判断预后的指标及指导内分泌治疗的参考。
作者 张文进
机构地区 河北医科大学第四医院乳腺中心
出处 《河北医药》 CAS 2013年第2期187-188,共2页 Hebei Medical Journal
关键词 乳腺癌 雄激素受体 免疫组织化学
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献11

  • 1Agoffs N, Swanson PE, Linden H, et al. Androgen receptor expression in estrogen receptor-negative breast cancer. Immunohistochemical, clinical, and prognostic associations. Am J Clin Pathol,2003,120:725-731.
  • 2Moinfar F, Okcu M, Tsybrovskyy O, et al, Androgen receptors frequetly are expressed in breast carcinomas:potential relevance to new therapeutic strategies. Cancer,2003,98:703-711.
  • 3VihkoR, Apter D. Endogenous steroids in the pathophysiology of breast cancer. CritRev Oncol Hematol, 1989,9 : 1-16.
  • 4Ando S, De Amicis F, Rago V, et al. Breast cancer: from estrogen to an- drogen receptor,Mol Cell Endocer,2002,193 :121-128.
  • 5Labile F, Dupont A, Belanger A. complete androgen blockade for the treatment of prostate cancer. New York : Lippincott, 1985.193-217.
  • 6王平.乳腺癌雄激素受体的研究进展[J].国外医学（肿瘤学分册）,1998,25(5):297-299. 被引量：3
  • 7Riva C, dainese E, Caprara G. Immunohistochemical study of angrogen re- ceptors in breast carcinoma. Evidence of their frequent expression in lob- ular carcinoma. Virchows Arch ,2005,447:695-700.
  • 8Yoshinari O,Eishu H. Androgen receptor expression in breast cancer:re- lationship with clinicopathological factors and biomarker. Int J Clin On- col ,2008,13:431-435.
  • 9Isola JJ. Immunohistochemieal demonstration of androgen recepter in breast cancer and its relationship to other prognostic factors. J Pathol, 1993.170:31-35.
  • 10Agoff SN, Swanson PE, Linden H, et al. Androgen Receptor Expression in Estrogen Receptor Negative Breast cancer: Immunohistochemical, Clinical, and Prognostic Associations. Am Jclin Pathol, 2003,120 : 725- 731.

二级参考文献5

  • 1Marco Di Monaco,Enrico Brignardello,Linda Leonardi,Valentina Gatto,Giuseppe Boccuzzi. Inhibitory effect of hydroxyflutamide plus tamoxifen on oestradiol-induced growth of MCF-7 breast cancer cells[J] 1995,Journal of Cancer Research and Clinical Oncology(12):710～714
  • 2Giuseppe Boccuzzi,Elena Tamagno,Enrico Brignardello,Marco Monaco,Manuela Aragno,Oliviero Danni. Growth inhibition of DMBA-induced rat mammary carcinomas by the antiandrogen flutamide[J] 1995,Journal of Cancer Research and Clinical Oncology(3):150～154
  • 3Reinhard Hackenberg,Thomas Hawighorst,Angelika Filmer,Abdolhamid Huschmand Nia,Klaus-Dieter Schulz. Medroxyprogesterone acetate inhibits the proliferation of estrogen- and progesterone-receptor negative MFM-223 human mammary cancer cells via the androgen receptor[J] 1993,Breast Cancer Research and Treatment(3):217～224
  • 4Carlos A. Encarnación,Daniel R. Ciocca,William L. McGuire,Gary M. Clark,Suzanne A. W. Fuqua,C. Kent Osborne. Measurement of steroid hormone receptors in breast cancer patients on tamoxifen[J] 1993,Breast Cancer Research and Treatment(3):237～246
  • 5Reinhard Hackenberg,Jürgen Hofmann,Gerda Wolff,Fritz H?lzel,Klaus -Dieter Schulz. Down-regulation of androgen receptor by progestins and interference with estrogenic or androgenic stimulation of mammary carcinoma cell growth[J] 1990,Journal of Cancer Research and Clinical Oncology(5):492～498

共引文献2

同被引文献47

  • 1Goldhirsch A, Wood WC, Coates AS, et al. Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St.Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol, 2011, 22(8): 1736.
  • 2Hall RE, Aspinall JO, Horsfall D J, et al. Expression of the androgen receptor and an androgen-reponsive protein, apolipoprotein D, in human breast cancer . Br J Cancer, 1996, 74(8): 1175.
  • 3Kim MJ, Ro JY, Ahn $11, et al. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and HER -2/neu overexpressing phenotype. Hum Pathol, 2006, 37(9): 1217.
  • 4Carey LA, Perou CM, Livasy CA, et al. Race, Breast cancer subtypes, and survival in the Carolina breast cancer study. JAMA, 2006, 295(21): 2492.
  • 5Ando S, De Amicis F, Rago V, et al. Breast cancer: from estrogen to androgen receptor . Mol CellEndocer, 2002, 193:121.
  • 6Yu Q,Niu N, Liu N, et al. Expression of androgen receptor in breast cancer and its significance as a prognostic factor . Ann Oncol, 2011, 22:1288.
  • 7Agoff SN, Swanson PE, Linden H, et al. Androgen receptor expression in estrogen receptor -negative breast cancer. Immunohistochemical, clinical, and prognostic association. Am J Clin Pathol, 2003, 120(5): 725.
  • 8Laura CC, Kimberly SC, Jonathan DM, et al. Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study . Mod Pathol, 2011, 24:924.
  • 9Waiters KA, Middleton L J, Joseph SR, et ai. Targeted loss of androgen re- ceptor signaling in murine granulosa cells of preantral and antral follicles causes female subfertility[J]. B iol Reprod, 2012, 87 (6) : 151.
  • 10Rodrigues JK, Navarro PA,Zelinski MB, et ai. Direct actions of androgens on the survival ,growth and secretion of steroids and anti-Mtillerian hor- mone by individual macaque follicles during three-dimensional culture[J]. Hum Reprod, 2015,30(3 ) : 664-674.

引证文献5

二级引证文献14

河北医药
2013年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部